Overall, our results were consistent with those of previous studies, suggesting that higher HDL and apoA1 levels protect against SARS-CoV-2 infection [5,6] as well as severe outcomes of COVID-19 [6,11,12]. The gene discussed is APOA1; the disease is COVID-19.